RHUMBLINE ADVISERS

Position in CRDF — Cardiff Oncology, Inc.

CIK 1115418 BOSTON, MA

Position in CRDF

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$39,083

-$80,628 QoQ

Shares Held

30,064

-59.3% QoQ

Ownership

0.039%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#42

of 104 holders

Holding Since

Jun 2021

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. CRDF ranks #296 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	396,380	$196,893,837
2	REGN	Regeneron Pharmaceuticals, Inc.	157,794	$98,390,870
3	MRNA	Moderna, Inc.	809,853	$56,714,005
4	ALNY	Alnylam Pharmaceuticals, Inc.	165,579	$49,844,246
5	INCY	Incyte Corp	428,533	$48,578,500
6	RVMD	Revolution Medicines, Inc.	226,008	$42,326,778
7	ROIV	Roivant Sciences Ltd.	1,178,789	$41,717,342
8	JAZZ	Jazz Pharmaceuticals plc	163,018	$39,282,447

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$39,083	30,064	-59.3%	Shares	Sole	2026-08-12
2026-03-31	$119,711	73,896	-5.7%	Shares	Sole	2026-05-12
2025-12-31	$220,273	78,389	-10.2%	Shares	Sole	2026-02-13
2025-09-30	$179,747	87,256	+2.9%	Shares	Sole	2025-11-06
2025-06-30	$266,990	84,759	+34.2%	Shares	Sole	2025-08-12
2025-03-31	$198,265	63,142	+18.8%	Shares	Sole	2025-05-29
2024-12-31	$230,766	53,172	+24.0%	Shares	Sole	2025-05-29
2024-09-30	$114,494	42,882	-6.8%	Shares	Sole	2024-11-12
2024-06-30	$102,104	45,993	-0.6%	Shares	Sole	2024-08-01
2022-03-31	$114,799	46,290	-0.6%	Shares	Sole	2022-05-12
2021-12-31	$279,969	46,584	-2.2%	Shares	Sole	2022-02-10
2021-09-30	$317,349	47,650	+4.3%	Shares	Sole	2021-11-12
2021-06-30	$303,838	45,690	—	Shares	Sole	2021-08-05
No filing history on record for this holder in this stock.